Fresh Equities
Raises
Markets
About
Looking for more information?

Contact our responsive and friendly client services team any time.

(03) 9028 2888

clients@freshequities.com

ASX:EX1 logo

ASX:EX1

Exopharm Limited

Health Care / Biotechnology

Current price

$0.62

0.025 (4.20%)

Last trade: Invalid date GMT

Market cap

$97.40m

Market closed

Investor Presentations

Principal Activity

Exopharm’s primary focus is to be a leader in the field of clinical human therapeutics using exosomes as regenerative medicine products. Exopharm is an Australian biopharmaceutical company that is seeking to develop and then commercialise exosomes as therapeutic agents – initially a product called Plexaris and later as a product called Exomeres – both being exosomes that are purified using the LEAP technology owned by Exopharm, its key asset.


Address

Level 1/888 Doncaster Rd, Doncaster East VIC 3109, Australia

News

Announcements

Filter

All categories
Investor Presentations
Trading Halt
Qtly Cashflow
Issued Capital
Periodic Reports
AnnouncementT+2 MovementDate

Rows per page:

5

0-0 of 0

Market Data

Day

3m

1yr

5yr

Current price

$0.62

Open price

-

Day low-high

-

Price change

-

Percent change

-

Previous close

-

Volume

-

Turnover

-

Bid price

-

Ask price

-

Market cap

-

Shares outstanding

-

Year high

-

Year low

-

Year low-high

-

Earnings per share

-

Price/earnings ratio

-

Dividend yield

-

Dividend per share

-

Franking

-

Investor Presentations

News

Sector Peers

CompanyMarket Cap
Fresh Equities
App Store
Play Store

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.

Contact Us

(03) 9028 2888

clients@freshequities.com

Address

Level 19, 15 William St
Melbourne VIC 3000
Australia

App Store
Play Store

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.